太原肛门肛裂太原肛门褶皱上有个泡,太原大便出鲜血不疼,太原大便手纸上有血,太原痔疮治疗时间,太原便血是何原因,山西干燥便血怎么办,太原女性痔疮

CHICAGO, Ill. – For the last few years, a refugee resettlement program in Chicago has been teaching women to be part of a social enterprise and improve their skill set. But as the Trump administration makes drastic cuts to the number of refugees accepted into the U.S., resettlement programs like this are bearing the brunt. With knitting needles in hand and sewing machines at the ready, women from all over the world, like Humaira, gather to learn from one another and create. “My name is Humaira. I’m from Afghanistan,” she said with a smile. Humaira is part of Loom, a group of refugee women artisans who congregate each week to create handmade functional crafts. Many have fled war and violence to resettle in the U.S. Loom Chicago Coordinator Rebecca Hamlin-Green says programs like this provide an opportunity for these women that might not otherwise be available. “Refugees in general face a lot of obstacles but women in particular do simply because they may be coming from a culture that doesn't emphasize employment or higher education or many of the skills and privileges that we enjoy,” she said. The program is administered by the Catholic Charities Refugee Resettlement Program in Chicago. Organizers say 70 percent of each sale price goes back to the women. “And then 30 percent goes back into the program so we can purchase their materials and provide the studio space,” explained Hamlin-Green. For many like Humaira, it’s not only a chance to make some extra money but to socialize and find community amongst other women – though they may not share the same language. “I like to make jewelry. I like to make crochet. And also knitting,” she said. But as of next year, the state department is capping the number of refugees allowed into the U.S. to 18,000, the lowest number since the refugee program was established in 1980. That’s an 80 percent cut from the 110,000 cap during the last year of the Obama administration. October became the first month on record in 30 years that not a single refugee was resettled in the U.S. And because federal dollars are tied directly to the number of arrivals, fewer refugees means fewer federal dollars for programs like Loom. Catholic Charities program director and former refugee Elmida Kulovic says they are feeling the pinch. “Basically, our program’s budgets are cut. So, for example in September this program lost four full-time positions,” said Kulovic. For now, the women at Loom are fortunate and thankful for a chance to escape persecution and poverty, while tens of thousands more have to wait. 2582

Atlanta 1979 was the start of a series of murders that terrorized the city for two years. Nearly 30 African Americans, mostly children and some as young as 9, were found murdered around the city. Catherine Leach-Bell's son, 13-year-old Curtis, was one of the victims in a string of murders between 1979 and 1981. “It hurt because we loved our children, and it really hurt,” she says. Atlanta's mayor, Keisha Bottoms, announced investigators are going to examine old evidence, using new technology to see if they can learn more about the murder cases. Many of them remain unsolved. “I want some closure. I want justice. I want to know who killed Curtis,” says his mother. “His case is still sitting on the shelf getting dusty and rusty.” A jury found Wayne Williams guilty for the murder of two adults. After his conviction, police blamed Williams for being responsible for most of the child murders, but he was never officially charged for those crimes. Williams has maintained his innocence, and some question whether he is responsible for all of the murders. Mayor Bottoms' announcement comes just days before Investigation Discovery's three-hour documentary series about the case, which airs tomorrow. “We'd like to think that the buzz around the film may have had something to do with her decision, but most important is the fact these victims who have so long looking to be heard seem to finally have been heard,” says Pamela Deutsch, an executive producer for the show.Investigators admit they don't know what they'll find and if it will change anything, but they say they owe it to the families to try to use new technology to find any possible new leads. 1675

If you’re on a budget, but still want to celebrate your love this weekend, you’re in luck. Several different businesses in the United States are offering special Valentine’s Day deals. Here are a few: 217

MYRTLE BEACH, S.C. – Hustle and bustle has returned to Johnny D’s Waffles and Benedicts. For chef and owner Jamie Daskalis, it’s a welcome sight. “It's been going really good the last week,” she said. We first visited 231

CHICAGO, Ill. – Scientists have identified nearly 70 drugs that could be effective in treating the coronavirus. But already, some drugs are being improperly prescribed or hoarded even before they can be adequately investigated and tested. For some who rely on the life-saving drugs for other ailments, shortages are already being felt. Across the country, some people with chronic illnesses are finding their much-needed medications are on backorder. One drug in short supply is Plaquenil, generically known as hydroxychloroquine sulfate. It’s used to treat malaria and chronic rheumatic diseases. “It prevents them from having severe pain, from their symptoms getting worse, from forming modules. This is a daily medication that these people absolutely need,” said Erin Fox, who’s with the American Society of Health-System Pharmacists. Fox, who maintains a list of nationwide drug shortages, says four of the eight producers of hydroxychloroquine are running out. “We’ve definitely seen a rapid increase in demand for this product,” she said. “I think it’s a frustrating problem and I think it’s really scary for those patients that rely on this medication day in and day out.” While hydroxychloroquine is not FDA-approved as an off-label treatment option for novel coronavirus, it has already been touted by the president as a potential game-changer. “Millions of units are ordered, and we’re going to see what happens,” said President Donald Trump. “We’re going to be talking to the governors about it, and the FDA is working on it right now.” Last week, a French study of just 20 people reported 70% of coronavirus patients treated with Plaquenil after six days tested negative for the virus, compared to 12.5% of the control group. Hospitals across the country are stockpiling it as a precaution. The state of New York has already acquired 70,000 doses as part of its own drug trials this week. But with no large-scale clinical data available, public health officials warn it’s too early to know whether the drug is effective against coronavirus. When asked about hydroxychloroquine’s efficacy at a White House coronavirus task force brief late last week, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, said more studies are needed. “The information that you’re referring to specifically is anecdotal; it was not done in a controlled clinical trial,” said Fauci. “So, you really can’t make any definitive statement about it.” Dr. Jessica Nouhavandi, the lead pharmacist and CEO of L.A.-based online pharmacy 2574